Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,834 | Dovepress* | 9,430+ | 746 | 10,176 | |
PubMed Central* | 404 | 143 | 547 | ||
Totals | 9,834 | 889 | 10,723 | ||
*Since 22 November 2018 |
View citations on PubMed and Google Scholar